Under the microscope: Medibio (ASX:MEB) - Claude Solitario, Managing Director

from Morgans Under the Microscope · host Morgans Financial Limited

Morgans Analyst Iain Wilkie chats with Claude Solitario, Managing Director of ASX listed mental health technology company Medibio (ASX:MEB). The two chat about an update on a recent partnership as well as a number of upcoming catalysts.

Episode metadata supplied by the publisher feed · Published Dec 3, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscope: Medibio (ASX:MEB) - Claude Solitario, Managing Director

0:00 19:59

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 19 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on December 3, 2020.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!